Givaudan's like-for-like sales grew 8.6% in the third quarter, almost twice the 4.7% growth analysts had forecast, as demand for luxury perfume scents drove the fragrance and flavour group's results.
Fragrance & Beauty lifts the group
Over the first nine months of 2026, Fragrance & Beauty generated CHF 3.15 billion (US$3.78 billion), an 8.8% like-for-like increase that exceeded the 8% growth recorded a year earlier. The division represented roughly 53% of the company's total sales in the period. In the third quarter, Fragrance & Beauty posted CHF 1.14 billion (US$1.37 billion) in sales, with like-for-like growth of 13.5%, up from 6.8% in the third quarter of 2025.
At group level, Givaudan recorded CHF 5.89 billion (US$7.08 billion) in sales for the first three quarters. The report shows a marked acceleration as the nine-month period closed. Vontobel analyst Arben Hasanaj said the acceleration should reinforce confidence in Givaudan's growth profile and resilience, according to Reuters. Analysts at Vontobel and Jefferies estimated that Fine Fragrance sales grew around 31% organically in the third quarter alone, Reuters reported.
Fine fragrance and consumer products
Within the division, Fine Fragrance sales rose 15.3% like-for-like, set against a competitive prior-year comparable of 18.7%. Givaudan said the back-to-back double-digit growth points to continued resilience in the business and strong demand across the premium perfume market.
Consumer Products sales increased 9.3% like-for-like against a prior-year comparable of 5.9%, a result Givaudan said indicates fragrance demand extends beyond fine perfumery into personal, oral, home and fabric care categories.
By contrast, Fragrance Ingredients and Active Beauty recorded a combined decline of 2.5% like-for-like, compared with an increase of 1.5% in the first nine months of 2025.
Currency, acquisitions and regions
Givaudan's like-for-like figures exclude acquisitions. On a reported basis, acquisitions added 2.8% to Fragrance & Beauty growth during the nine-month period, while currency translation had a negative impact of 3.8%. At group level, acquisitions contributed 1.4%. Givaudan highlighted two transactions: the acquisitions of Belle Aire Creations for CHF 62 million (US$74.48 million) and Vollmens Fragrances for CHF 20 million (US$24 million).
Asia Pacific was the fastest-growing geography at group level, with sales up 10.6% like-for-like in the first nine months of 2026, compared with 4.6% a year earlier. Sales in South Asia, Africa and the Middle East rose 4.1% like-for-like, against comparable growth of 8.8% in the prior-year period. Europe grew 1.5% like-for-like, compared with 3.8% a year earlier, and Latin America grew 1.1%, against 3.1% previously. High-growth markets advanced 7.9%, versus 2.7% in mature markets.
North America was the most challenging region: Taste & Wellbeing sales fell 3.3% like-for-like, compared with a 3.9% decline in the first nine months of 2025, although the region overall grew 1.1%. Givaudan attributed the drop mainly to continued weakness in its Health and Functional business unit and to US tariff refunds made to Givaudan customers during the third quarter of 2026.
The company said its performance reflected consistent growth despite geopolitical and macroeconomic volatility, describing this as evidence of market resilience. Following the update, Givaudan shares rose nearly 7%, reaching a 15-month high, and the results had a positive ripple effect on peers: Reuters reported that shares in dsm-firmenich, Novonesis and Symrise rose between 1.6% and 3.1% in early trading.
